Athyrium Capital Management, LP

Profile

Athyrium Capital Management is a private equity firm based in New York, founded in 2008. The firm was established by industry veterans who previously held senior roles in various financial institutions. Athyrium boasts a diverse team comprising experts with backgrounds in finance, private equity, and healthcare sectors. What sets them apart is their strong emphasis on healthcare investments and their ability to leverage deep industry expertise for value creation.

Athyrium primarily invests in healthcare and life sciences with a focus on healthcare services, pharmaceuticals, and medical devices sectors. The firm looks to deploy check sizes ranging from $10 million to $100 million across various stages including Series B and Late Stage. While their primary geographic focus is North America, they have a global reach facilitated by their substantial assets under management. Some of their notable funds include Athyrium Opportunities Funds.

The firm has a history of making successful investments in notable companies. Their portfolio includes healthcare innovators and companies poised for growth in the medical field. They have invested in a mix of startups and established players, allowing them to drive growth and achieve successful exits through sales to strategic investors or IPOs.